Author: GlobeNewswire

Clinical data presented at the AACR meeting supports a differentiated safety profile for ELU001 in patients with solid tumorsNo evidence…

REYKJAVIK, Iceland, April 19, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today…

Montrouge, France, April 19, 2023 DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After…

SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the…

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 19, 2023 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical…

PALM BEACH GARDENS, Fla., April 19, 2023 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company focused on accelerating…

Hypoimmune-modified CD19-directed CAR T cells persist and remain functional in preclinical models over multiple months in an allogeneic humanized immune…

REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced…

TORONTO, April 18, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R),…